Over the last 30 days, the Zacks Consensus Estimate has changed +3.5%. The overall direction and magnitude of estimate revisions translate into a Zacks Rank #1 (Strong Buy) for Fresenius.

Nevro (NVRO) shares ended the last trading session 13.9% higher at $5.72. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This ...

Nevro appears a compelling earnings-beat candidate. However, investors should pay attention to other factors too for betting on this stock or staying away from it ahead of its earnings release.

It has been about a month since the last earnings report for Nevro (NVRO). Shares have added about 0.9% in that time frame, outperforming the S&P 500. Will the recent positive trend continue ...